Stay informed with our latest blog posts, addressing critical topics and trends relevant to growth markets. Our blogs provide timely perspectives from our community of experts and thought leaders.
MIT GCFP Visiting Scholar and former Boston Fed President Eric Rosengren discusses the Federal Reserve’s policy outlook amid persistent inflation and growing political pressure.
MIT Sloan Senior Lecturer and former President of Fidelity Investments Bob Pozen discusses the implications of changing corporate financial reporting practices.
MIT GCFP Visiting Scholar and former Boston Fed President Eric Rosengren weighs in on how the government shutdown affects the Federal Reserve’s access to economic data.
For Adriana Bokel Herde, EMBA ’17, the MIT Executive MBA was a turning point—one that reshaped her confidence, expanded her career across industries, and redefined her approach to principled leadership. From overcoming imposter syndrome to applying hands-on, people-centered problem solving, Bokel He...
Can giving low-wage workers more of a voice on the job improve their mental health? A just-published paper in the American Journal of Public Health finds signs that the answer may be “yes.”
Join the MIT Climate Policy Center in welcoming Didem Nisanci to the Global Climate Policy Project (GCPP) at Harvard and MIT as a Senior Fellow for Climate and Geoeconomics.
Zana Buçinca, a scholar whose research interests include human-AI interaction and the future of work, will be joining the faculty of the MIT Institute for Work and Employment Research (IWER) in the fall of 2026 when she joins the MIT Sloan School of Management’s Work and Organization Studies group ...
Three members of the faculty of the MIT Institute for Work and Employment Research (IWER) have received seed grants from MIT to produce papers exploring some of the societal impacts of generative artificial intelligence.
On Nov. 12, 2025, Dr. Harison Hong, Executive Director and Brand Lead at Astria Therapeutics, and Tim Sun of Google’s Cloud AI GTM team, discussed the role and impact of AI in the pharmaceutical industry development and sales cycles.
